Analyst Ratings January 27, 2026

BMO Lifts Baker Hughes Price Target to $65, Citing Strong IET Quarter and Improved Guidance

Analyst raises EPS and EBITDA forecasts after solid fourth-quarter Industrial & Energy Technology performance and robust power market demand

By Ajmal Hussain BKR
BMO Lifts Baker Hughes Price Target to $65, Citing Strong IET Quarter and Improved Guidance
BKR

BMO Capital Markets has increased its 12-month price objective on Baker Hughes from $55 to $65 while keeping an Outperform rating. The forecast change follows stronger-than-expected fourth-quarter 2025 results from the Industrial & Energy Technology (IET) segment and upgraded guidance for 2026, prompting BMO to raise near- and full-year earnings and EBITDA estimates.

Key Points

  • BMO raises Baker Hughes price target to $65 from $55 and keeps an Outperform rating.
  • The upgrade follows strong Q4 2025 IET results, margin gains, and improved 2026 guidance, with power exposure noted as a strength.
  • BMO increased Q1 2026 EPS to $0.53 and EBITDA to $1.07 billion; full-year 2026 EPS to $2.60 and EBITDA to $4.87 billion; 2027 EPS forecast set at $2.94 and EBITDA at $5.29 billion.

Overview

BMO Capital has raised its price target for Baker Hughes (BKR) to $65.00 from $55.00, while maintaining an Outperform rating on the shares. The stock is trading at $56.29, slightly under its 52-week high of $56.89, and has returned 32.02% over the last 12 months.


Driver of the change

BMO tied the higher price target to a strong fourth-quarter 2025 performance from Baker Hughes’ Industrial & Energy Technology (IET) business and to management’s improved guidance for 2026. The bank highlighted margin expansion within IET as well as firm demand across the segment’s end markets, with notable exposure to power identified as a particular strength.


Revised estimates

Following the quarter, BMO adjusted several near- and full-year forecasts for Baker Hughes. The firm lifted its first-quarter 2026 earnings-per-share (EPS) estimate by 9.2% to $0.53 and raised its Q1 EBITDA projection by 5.7% to $1.07 billion. For the full year 2026, BMO increased its EPS estimate by 2.6% to $2.60 and its EBITDA estimate by 2.0% to $4.87 billion.

Looking further ahead, BMO’s model projects 2027 EPS of $2.94 and EBITDA of $5.29 billion for Baker Hughes, excluding GTLS in its estimates.


Valuation context

BMO observed that Baker Hughes’ shares currently trade at roughly 14 times 2026 EBITDA on the IET segment - a multiple the bank described as below peer group levels, which it characterized as typically residing in the high-teens to low-twenties range. Baker Hughes carries a market capitalization of $55.55 billion.


Quarterly results that influenced the outlook

Baker Hughes reported fourth-quarter 2025 results that topped consensus expectations. Adjusted EPS for the period came in at $0.78, ahead of a $0.67 projection. Revenue for the quarter was $7.39 billion versus an anticipated $7.07 billion. The company’s Q4 performance underpinned the positive reassessment by BMO and was singled out for margin gains and strong demand in IET end markets.


Market and analyst activity

While the company’s results drew a favorable market response, there were no material mergers or acquisitions announced for the period, and analyst coverage did not produce any notable upgrades or downgrades beyond the actions described by BMO.


Conclusion

BMO’s decision to increase the price target reflects a combination of better-than-expected IET results, stronger guidance for 2026, and upward revisions to near- and full-year earnings and EBITDA estimates. The bank’s view also highlights a relative valuation gap versus peers on an IET EBITDA multiple basis.

Risks

  • Company guidance and results could vary from BMO’s revised estimates, affecting EPS and EBITDA forecasts - impacts energy and industrials sectors.
  • Valuation comparison shows Baker Hughes trading at roughly 14x 2026 IET EBITDA versus peers in the high-teens to low-twenties; if peer multiples change, perceived discount could narrow or widen - impacts investor sentiment and energy sector valuations.
  • No significant mergers or acquisitions were reported during the period, and there were no notable analyst upgrades or downgrades beyond BMO’s action; limited analyst activity could affect market information flow - impacts capital markets and institutional investor assessment.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026